Yes, Enchondromas Are Benign Cartilage Tumors
Enchondromas are definitively benign cartilaginous tumors that arise in the medullary cavity of bone and are composed of mature hyaline cartilage 1, 2. They represent the most common benign cartilage tumor, particularly in the small tubular bones of the hands and feet 3.
Key Characteristics
Enchondromas are:
- Benign lesions that rarely undergo malignant transformation 2, 4
- Most commonly located in the ulnar-sided tubular bones of the hand, particularly the proximal phalanx 1
- Often discovered incidentally on imaging performed for other reasons 5, 4
- Characterized by IDH1 or IDH2 mutations in approximately 50% of cases 6, 7
Critical Diagnostic Challenge
The major clinical pitfall is distinguishing enchondromas from low-grade chondrosarcomas (atypical cartilaginous tumors/grade I chondrosarcomas), as they can have significant overlap in imaging and histopathology 2, 8. This differentiation requires:
- Multidisciplinary evaluation including musculoskeletal oncologist, radiologist, and pathologist 2
- Clinical correlation: Pain at the site of a cartilaginous lesion may indicate malignancy 6
- Advanced imaging: Dynamic contrast-enhanced MRI can aid differentiation 6
- Location matters: Lesions in long bones of the appendicular skeleton are more likely benign, while axial/pelvic locations warrant higher suspicion 6
Management Approach
For asymptomatic, stable enchondromas: observation with periodic radiographic surveillance is appropriate 2, 5, 4. The evidence suggests:
- Plain radiographs every 3-6 months for the first year, then annually for at least 3 years total 5
- Avoid unnecessary MRI imaging unless clinical or radiographic concern develops 5
- Growth is rare (5.45% in one series) and typically occurs around 2 years follow-up 5
Surgical intervention is indicated for:
- Symptomatic lesions causing pain 1, 3
- Lesions larger than 3-4 cm 1
- Pathological fracture 4, 3
- Expanding lesions on surveillance 4
Surgical technique: Simple intralesional curettage with or without bone grafting is the treatment of choice 2, 4, 3. Adjuvant treatments like high-speed burring or chemical adjuvants are not routinely recommended 4.
Important Caveats
- Biopsy results can be discordant or inconclusive 8, requiring repeat sampling and multidisciplinary tumor board discussion
- The distinction between enchondroma and atypical cartilaginous tumor/grade I chondrosarcoma can be extremely difficult even for experienced pathologists 6, 2
- Malignant transformation risk is very low but not zero, justifying surveillance protocols 5